• Latest Posts
In Depth 26 Oct 2023

Behind closed doors: The unseen controversies and scandals in Alzheimer’s drug trials

U.S. approval for psychedelic drug MDMA nears after success in clinic

FDA grants breakthrough therapy designation to Duchenne muscular dystrophy treatment

Molecure raises $12M and gets FDA clearance for pulmonary sarcoidosis trial

FDA approves Beyfortus ahead of 2023-24 RSV season

FDA approves BioMarin gene therapy for hemophilia A

ADVERTISEMENT

FDA gives Orphan Drug Designation to CellCentric multiple myeloma drug

FDA puts hold on Arcellx myeloma program following patient death

Nordic Bioscience cancer biomarker gets FDA go ahead

Minoryx can start phase 3 trial for cerebral adrenoleukodystrophy patients

von Willebrand disease treatment gets FDA orphan drug designation

ADVERTISEMENT